# The Medicines (Products for Human Use) (Fees) Regulations 2016, Regulation 3: Interpretation of Part 2


In this Part—
“EU marketing authorisation” means—
(a)a United Kingdom marketing authorisation granted by the licensing authority under Part 5 (marketing authorisations) of the Human Medicines Regulations;
(b)a marketing authorisation granted by the competent authority of an EEA State other than the United Kingdom in accordance with the 2001 Directive; or
(c)a European Union marketing authorisation; and
“relevant medicinal product” means a medicinal product for human use to which the provisions of the 2001 Directive apply.

---
Source: https://www.legislation.gov.uk/uksi/2016/190/regulation/3 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/regulation-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.